Skip to main content
. Author manuscript; available in PMC: 2016 Feb 19.
Published in final edited form as: Physiol Behav. 2015 Aug 7;151:379–385. doi: 10.1016/j.physbeh.2015.08.011

Table 1.

Sample characteristics (N=120).

Variable Addison's
disease
Healthy
controls
t / χ2 p ESE
(n=60) (n=60)
Age at diagnosis (years)a 31.03 (14.41)
3–67
Duration of AD (years)a 19.33 (13.34)
1–54
Total hydrocortisone doseb 22.02 (7.23)
5–35
Hydrocortisone/kgc 0.31 (0.14)
0.10–0.70
Number of doses per dayd 1.95 (0.70)
1–3
Concurrent co-morbid
 diseases
1.63 (1.71)
0–7
Age 50.57 (14.37)
20–74
49.90 (14.70)
19–77
−0.26 .792 0.05
Body mass index 26.80 (6.02)e 24.82 (4.02)f −1.99 .049* 0.39
18.37–42.19 18.20–37.81
Income (in ZAR)g 4.92 .426 0.21
 1000–2499 4 1
 2500–5499 8 6
 5500–9999 11 7
 10,000–19,999 10 10
 20,000–30,000 6 11
 >30,000 15 19

Note. Body mass index was calculated by dividing the participant's weight by height2 (information obtained from the sociodemographic questionnaire). For all of the variables except Income, means (with standard deviations in parentheses) are presented on the top line, and range is presented below that. Regarding the variable Income, ZAR=South African rands; when the study was conducted, the ZAR:US$ exchange rate was 8.65:1. For that variable, actual numbers of participants in each cell are presented. ESE=effect size estimate; in this case, Cohen's d (for the t-tests), or Cramer's V (for the χ2 test).

a

Data based on 58 participants.

b

Data based on 52 participants; 2 patients did not provide the relevant answers on the sociodemographic questionnaire, and the remaining 6 were prescribed prednisone.

c

Data based on 51 participants; 3 patients did not provide the relevant answers on the sociodemographic questionnaire, and the remaining 6 were prescribed prednisone.

d

Data based on 59 participants.

e

Data based on 48 participants.

f

Data based on 55 participants.

g

Data based on 54 participants in each group.

*

p < .05.